How to Help Your Patients Find Bss Ophthalmic Solution in Stock: A Provider's Guide

Updated:

March 28, 2026

Author:

Peter Daggett

Summarize this blog with AI:

A practical guide for ophthalmologists and surgical centers on ensuring Bss Ophthalmic Solution availability and keeping patients' surgeries on track.

Your Patients Are Counting on You to Have Bss Ophthalmic Solution Ready

When a patient is scheduled for cataract surgery or another ophthalmic procedure, the last thing they expect to hear is that a critical surgical supply might not be available. But Bss Ophthalmic Solution (Balanced Salt Solution) — the sterile irrigating solution used in virtually every eye surgery — has experienced intermittent supply challenges that affect surgical centers nationwide.

As a provider, you're in the best position to anticipate these supply issues and protect your patients from delays. This guide outlines practical strategies for ensuring BSS availability, managing patient expectations, and building a resilient surgical supply chain.

Current Availability: What You Need to Know

As of 2026, Bss Ophthalmic Solution supply is adequate but variable. Key points:

  • Alcon remains the dominant manufacturer of FDA-approved BSS (BSS Sterile Irrigating Solution in 15 mL and 30 mL sizes) and BSS Plus (500 mL).
  • Periodic backorders occur through major distributors (McKesson, Cardinal Health, Medline), with lead times extending to 2–3 weeks during constrained periods.
  • New entrants like ZEISS (Puri Clear BSS) are gradually expanding the supply base, but market diversification remains a work in progress.
  • Generic Balanced Salt Solution is available from multiple manufacturers at $15–$50 per 500 mL for institutional purchasers, but FDA-approval status should be verified.

For the full supply timeline and background, see our provider briefing: Bss Ophthalmic Solution Shortage: What Providers and Prescribers Need to Know in 2026.

Why Patients Can't Find Bss Ophthalmic Solution on Their Own

Unlike most medications, BSS is not a retail pharmacy product. Patients can't call Walgreens or CVS to check stock. This creates unique challenges:

  • Institutional supply chain: BSS is ordered through medical supply distributors, not pharmacy benefit managers. Patients have no direct access to procurement channels.
  • No coupon or discount card programs: Because BSS is a surgical supply billed as part of the facility fee, there are no GoodRx-style savings cards for patients.
  • Limited patient awareness: Most patients don't know what BSS is until they're told their surgery depends on it. When they hear about a shortage, they feel helpless.

This is why provider-side supply management is so critical. Your patients are relying on your team to handle this.

What Providers Can Do: 5 Practical Steps

Step 1: Maintain Buffer Inventory

The single most effective strategy is keeping a minimum of 2–4 weeks' worth of BSS supply on hand at all times. This buffer absorbs short-term backorders without affecting surgical schedules.

Tips for implementation:

  • Track weekly BSS consumption by product (standard BSS vs. BSS Plus) and size (15 mL, 30 mL, 500 mL).
  • Set reorder points that trigger restocking before inventory drops below the buffer threshold.
  • Include BSS in your monthly supply chain review alongside other critical surgical consumables.

Step 2: Diversify Supplier Relationships

Relying on a single distributor for BSS is a single point of failure. Consider:

  • Establishing accounts with at least two medical supply distributors (e.g., McKesson and Cardinal Health).
  • Exploring direct purchasing from Alcon or their authorized specialty distributors.
  • Evaluating emerging products like ZEISS Puri Clear BSS that may be available through different distribution channels.

Step 3: Qualify Alternative Products

Don't wait for a shortage to evaluate alternatives. Build a formulary that includes:

  • BSS Plus: Alcon's enriched formulation ($35–$90 per 500 mL). Superior corneal endothelial protection; appropriate for procedures of any duration.
  • Endosol Extra: FDA-approved balanced salt solution. A direct substitute for standard BSS in most clinical scenarios.
  • Navstel: Enriched with hypromellose, dextrose, and glutathione. Particularly suitable for complex or prolonged procedures.

Ensure all surgeons in your practice or facility are familiar with these alternatives and comfortable using them. For a clinical comparison, see Alternatives to Bss Ophthalmic Solution.

Step 4: Communicate Proactively With Patients

If your practice is experiencing BSS supply concerns, communicate with patients before they hear about it from an unexpected rescheduling call:

  • At the pre-op appointment, briefly explain that you monitor surgical supply availability and have contingency plans in place.
  • If a supply issue may affect scheduling, notify patients as early as possible and offer alternative dates or facilities.
  • Direct concerned patients to trusted information sources like the Medfinder patient shortage update.

Step 5: Use Tracking Tools

Medfinder for Providers offers real-time availability data and shortage alerts specifically designed for healthcare professionals:

  • Search BSS products across multiple distributors and regions.
  • Set alerts for supply status changes.
  • Access alternative product guides for quick clinical reference.

Other monitoring resources include the FDA Drug Shortage Database and the ASHP Drug Shortage Resource Center.

Alternatives at a Glance

Here's a quick-reference comparison for your formulary team:

  • BSS Sterile Irrigating Solution (Alcon): Standard irrigating solution for procedures under 60 minutes. 15 mL and 30 mL sizes. Cost: $8–$25/unit.
  • BSS Plus (Alcon): Enriched with bicarbonate, dextrose, glutathione. For procedures of any duration. 500 mL. Cost: $35–$90/unit.
  • Endosol Extra: FDA-approved balanced salt solution. Direct BSS substitute. Contact manufacturer for current pricing and availability.
  • Navstel: Enriched BSS with hypromellose. Suitable for complex procedures. Contact manufacturer for pricing.
  • ZEISS Puri Clear BSS: Newer entrant. Balanced salt solution designed for ocular surgery. Growing U.S. distribution.

Workflow Tips for Surgical Centers

Integrate BSS supply management into your existing workflows:

  • Weekly inventory check: Add BSS to your weekly surgical supply audit. Flag any product below buffer levels immediately.
  • Pre-case verification: Include BSS availability in your pre-operative checklist for each surgical day.
  • Surgical coordinator training: Ensure coordinators know who to contact for emergency BSS procurement and what alternatives are approved for use at your facility.
  • Quarterly supply review: Review BSS procurement costs, usage trends, and supplier performance quarterly. Adjust contracts and inventory targets as needed.

Final Thoughts

BSS supply management may not be the most glamorous aspect of running an ophthalmic practice, but it's essential. A few hours of planning and process improvement can prevent the frustration and patient harm that comes from last-minute surgical cancellations.

Build your buffer, diversify your suppliers, qualify your alternatives, and use tools like Medfinder for Providers to stay ahead of supply disruptions. Your patients are counting on it.

For the patient-facing version of this information that you can share with surgical candidates, see How to Find Bss Ophthalmic Solution in Stock Near You. And for cost management strategies that benefit both your practice and your patients, read How to Help Patients Save Money on Bss Ophthalmic Solution: A Provider's Guide.

How much BSS inventory should a surgical center keep on hand?

A minimum of 2–4 weeks' worth of BSS supply is recommended as a buffer against short-term backorders. Track weekly consumption by product type and size, and set reorder points that trigger restocking before inventory drops below the buffer threshold.

Should we switch entirely to BSS Plus to avoid standard BSS shortages?

BSS Plus provides equal or superior tissue protection and can replace standard BSS for any procedure. However, it costs significantly more ($35–$90 per 500 mL vs. $8–$25 per 15 mL for standard BSS). A mixed inventory of both products provides the best balance of cost management and supply resilience.

How do we verify that a generic Balanced Salt Solution is FDA-approved?

Check the FDA's Drugs@FDA database for approved NDA/ANDA listings. The FDA designates BSS, BSS Plus, and Endosol Extra as reference listed drugs. Any generic should have an approved ANDA referencing one of these products. Be cautious with products marketed without clear NDA/ANDA documentation.

What tools can help us track BSS availability across distributors?

Medfinder for Providers (medfinder.com/providers) offers real-time availability tracking and shortage alerts. The FDA Drug Shortage Database and ASHP Drug Shortage Resource Center provide official shortage status updates. Additionally, establish direct communication channels with your distributor account representatives for the most current stock information.

Why waste time calling, coordinating, and hunting?

You focus on staying healthy. We'll handle the rest.

Try Medfinder Concierge Free

Medfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.

25,000+ have already found their meds with Medfinder.

Start your search today.
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast-turnaround time
Never call another pharmacy